This morning, Johnson & Johnson shared its 2025 second-quarter earnings report.
Since its founding in 1886, the company has been committed to innovation—today, more than 138,000 employees across the globe work to deliver solutions for patients around the world and to help profoundly impact health for humanity.
“Based on our strong second-quarter results, Johnson & Johnson is raising our full year outlook for sales and EPS,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “We also have heightened confidence for our long-term expectations as we advanced many significant pipeline programs across our diversified portfolio. We continue to be very well positioned to invest in breakthrough healthcare solutions that benefit patients and deliver long-term sustainable growth for shareholders.”
For more details about the company’s 2025 second-quarter results and to read a message from Chairman and Chief Executive Officer Joaquin Duato, here’s an infographic highlighting key stats.
